OTC Pet Medication Market 2022
OTC Pet Medication Market to Expand US$ 45 Bn by 2030; Supply Chain Disruption Due to Covid-19 Pandemic Hindering Market Growth
Get Sample Copy@https://www.persistencemarketresearch.com/samples/31512
With rising ownership of companion animals and pets across the world, both, the pet food and pet medication markets have been thriving. As per the American Pet Products Association, Inc. (APPA), in 2019, U.S. pet expenditure was US$ 95.7 Bn, among which, supplies, live animals, and OTC medicines were worth US$ 19.2 Bn. A lot of pets experience health concerns such as arthritis, flee issues, skin allergies, worm-related problems, etc., which can be cured by OTC drugs. This, in turn, is propelling the growth of the OTC pet medication market across the globe.
On the back of these factors, the OTC pet medication market is projected to expand around 1.5 times in current size by the year 2030, progressing at a CAGR of more than 4% over the forecast period of 2020–2030.
Request For Customization@https://www.persistencemarketresearch.com/request-customization/31512
Key Takeaways of Global OTC Pet Medication Market Study
- There are less number of players having a significant share in the global OTC pet medication market. These prominent players considerably focus on product innovation with natural ingredients, and new product launches.
- Manufacturers are incorporating various technological advancements and introducing new formulations such as anti-infective and antiparasitic OTC pet medication to meet the growing demand for safe OTC pet medication.
- Most OTC pet medication is demanded for dogs, cats, birds, and fish & reptiles; these held around 87% of the total OTC pet medication market share in 2019.
- North America and Europe are the top regions when it comes to pet ownership, which is why they lead in terms of share in the global OTC pet medication market.
- Restrictions and lockdowns across the world due to the Covid-19 pandemic have resulted in disruptions in the supply chain of the OTC pet medication market, compounded by production and raw material procurement issues.
“Prominent companies in the OTC pet medication market can gain significant market share by introducing natural medicines for pets. A few companies have already started, even though it is a new concept; hence, the opportunity lies, especially in emerging markets,” says a PMR analyst.
Key Players in OTC Pet Medication Market
PMR’s report underlines groundbreaking insights into the competitive scenario of the OTC pet medication market, along with highlights of the differential strategies used by manufacturers. Some of the key players identified across the value chain of the global OTC pet medication market include Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva Sante Animale, Bayer Companion Animal, , Zoetis Inc., Virbac SA, Vetoquinol SA, Frontline, Elanco, and others.
Buy Now@https://www.persistencemarketresearch.com/checkout/31512
Key Questions Answered in This Report.
- What will the Market growth rate in Future?
- What are the key factors driving the global Market?
- Who are the key manufacturers in Market space?
- What are the opportunities and threats faced by the vendors in the global industry?
- What are sales, revenue, and price analysis by regions of industry?
About PersistenceMarketResearch:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353